| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
86,945 |
77,136 |
$6.59M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
48,749 |
42,292 |
$5.38M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
18,896 |
16,129 |
$2.76M |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
10,994 |
9,700 |
$1.04M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
26,427 |
6,500 |
$777K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
20,582 |
15,990 |
$726K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
13,780 |
12,362 |
$688K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
34,488 |
27,656 |
$678K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
14,836 |
10,426 |
$655K |
| 80053 |
Comprehensive metabolic panel |
78,480 |
63,595 |
$511K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13,613 |
10,277 |
$483K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
93,409 |
74,762 |
$443K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,191 |
2,948 |
$405K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
5,371 |
4,666 |
$393K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
14,338 |
10,019 |
$390K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,344 |
1,149 |
$374K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,681 |
2,309 |
$357K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
10,658 |
9,513 |
$331K |
| 71045 |
Radiologic examination, chest; single view |
15,603 |
13,577 |
$304K |
| 71046 |
Radiologic examination, chest; 2 views |
10,061 |
8,777 |
$261K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
18,843 |
15,911 |
$259K |
| 36415 |
Collection of venous blood by venipuncture |
97,446 |
76,958 |
$180K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,641 |
1,920 |
$144K |
| 95811 |
|
288 |
271 |
$133K |
| 87631 |
|
4,940 |
4,013 |
$121K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
6,907 |
2,046 |
$117K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,956 |
1,626 |
$111K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
1,111 |
747 |
$110K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,124 |
1,615 |
$102K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,543 |
1,662 |
$102K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
220 |
204 |
$80K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,517 |
6,502 |
$79K |
| 87653 |
|
2,502 |
2,265 |
$75K |
| 86738 |
|
6,814 |
6,087 |
$73K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
735 |
662 |
$71K |
| 81025 |
|
10,769 |
9,469 |
$67K |
| 76830 |
Ultrasound, transvaginal |
552 |
507 |
$66K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,021 |
1,250 |
$65K |
| 84484 |
|
9,756 |
7,586 |
$64K |
| 81001 |
|
35,867 |
29,855 |
$62K |
| 80061 |
Lipid panel |
6,626 |
5,848 |
$58K |
| 99215 |
Prolong outpt/office vis |
1,208 |
1,097 |
$57K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,733 |
2,329 |
$53K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,363 |
4,061 |
$48K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,179 |
1,004 |
$41K |
| 95813 |
|
235 |
219 |
$40K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
996 |
694 |
$39K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,381 |
4,285 |
$36K |
| C1769 |
Guide wire |
1,878 |
1,384 |
$33K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,541 |
5,367 |
$32K |
| 86803 |
|
2,712 |
2,209 |
$31K |
| 87088 |
|
5,006 |
4,114 |
$30K |
| 74019 |
|
916 |
801 |
$28K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
88 |
80 |
$28K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
945 |
240 |
$27K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
577 |
494 |
$26K |
| G0378 |
Hospital observation service, per hour |
822 |
617 |
$24K |
| 83690 |
|
5,426 |
4,570 |
$24K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,215 |
1,001 |
$22K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
12,500 |
10,915 |
$21K |
| 83880 |
|
1,083 |
891 |
$20K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,171 |
2,753 |
$20K |
| 86780 |
|
1,838 |
1,442 |
$20K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
136 |
79 |
$19K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
735 |
602 |
$19K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
730 |
600 |
$19K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,707 |
1,378 |
$18K |
| 87449 |
|
1,444 |
1,227 |
$16K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,048 |
951 |
$16K |
| 80055 |
|
830 |
704 |
$16K |
| 83735 |
|
4,145 |
3,507 |
$16K |
| 86900 |
|
2,193 |
1,593 |
$15K |
| 81003 |
|
12,883 |
10,001 |
$15K |
| 84436 |
|
4,182 |
3,708 |
$15K |
| 37252 |
|
27 |
27 |
$14K |
| 86762 |
|
1,381 |
1,068 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
465 |
397 |
$14K |
| 84479 |
|
4,186 |
3,709 |
$14K |
| 86850 |
|
3,007 |
1,641 |
$14K |
| 86703 |
|
1,364 |
1,106 |
$13K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
38 |
29 |
$13K |
| 87340 |
|
1,712 |
1,353 |
$13K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,500 |
3,547 |
$12K |
| 76770 |
|
322 |
280 |
$12K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
10,967 |
9,071 |
$11K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
407 |
380 |
$11K |
| 83970 |
|
326 |
283 |
$11K |
| 87481 |
|
266 |
222 |
$11K |
| 86140 |
|
2,797 |
2,396 |
$10K |
| 84702 |
|
898 |
635 |
$10K |
| 86901 |
|
2,207 |
1,595 |
$10K |
| 87081 |
|
1,661 |
1,422 |
$10K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
132 |
118 |
$10K |
| 95886 |
|
89 |
73 |
$9K |
| 0223U |
|
47 |
42 |
$9K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
43 |
36 |
$9K |
| C1753 |
Catheter, intravascular ultrasound |
72 |
61 |
$9K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
190 |
91 |
$9K |
| 81513 |
|
95 |
89 |
$9K |
| 82550 |
|
2,242 |
1,815 |
$9K |
| 93975 |
|
130 |
108 |
$9K |
| 85651 |
|
2,915 |
2,500 |
$9K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,197 |
4,769 |
$8K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
502 |
430 |
$8K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
296 |
223 |
$7K |
| 76775 |
|
219 |
187 |
$7K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
43 |
36 |
$7K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
92 |
34 |
$7K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,073 |
730 |
$7K |
| 82042 |
|
1,445 |
1,227 |
$6K |
| 82150 |
|
1,536 |
1,229 |
$6K |
| 82728 |
|
575 |
510 |
$6K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
14 |
13 |
$6K |
| 86160 |
|
690 |
369 |
$6K |
| 83021 |
|
419 |
320 |
$6K |
| 96417 |
|
187 |
101 |
$6K |
| 82553 |
|
878 |
707 |
$5K |
| 82570 |
|
1,458 |
1,228 |
$5K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,208 |
1,050 |
$5K |
| 96376 |
|
167 |
68 |
$5K |
| 80074 |
|
169 |
133 |
$5K |
| 75822 |
|
47 |
41 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
974 |
856 |
$5K |
| 82947 |
|
1,785 |
1,136 |
$5K |
| 72100 |
|
224 |
202 |
$5K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
42 |
26 |
$4K |
| 96415 |
|
154 |
74 |
$4K |
| 85379 |
|
692 |
582 |
$4K |
| 82950 |
|
1,353 |
866 |
$4K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
53 |
41 |
$4K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
26 |
12 |
$4K |
| 86592 |
|
1,189 |
1,042 |
$4K |
| 82607 |
|
427 |
335 |
$4K |
| 71250 |
|
33 |
27 |
$4K |
| 84439 |
|
561 |
481 |
$4K |
| 87400 |
|
628 |
292 |
$4K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
100 |
90 |
$3K |
| 84100 |
|
1,128 |
969 |
$3K |
| 85730 |
|
1,254 |
1,086 |
$3K |
| 87040 |
|
632 |
332 |
$3K |
| 72141 |
|
13 |
13 |
$3K |
| J3230 |
Injection, chlorpromazine hcl, up to 50 mg |
232 |
208 |
$3K |
| 84550 |
|
1,059 |
909 |
$3K |
| 82746 |
|
286 |
230 |
$3K |
| 85610 |
|
1,618 |
1,422 |
$3K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
14 |
14 |
$3K |
| 94726 |
|
105 |
83 |
$3K |
| 82677 |
|
120 |
104 |
$3K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,988 |
1,069 |
$2K |
| 86787 |
|
310 |
204 |
$2K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
14 |
13 |
$2K |
| 73560 |
|
96 |
59 |
$2K |
| 37253 |
|
25 |
25 |
$2K |
| 80320 |
|
1,930 |
1,321 |
$2K |
| 82105 |
|
166 |
143 |
$2K |
| 77336 |
|
66 |
27 |
$2K |
| 82164 |
|
238 |
176 |
$2K |
| 82043 |
|
492 |
421 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,491 |
784 |
$2K |
| 86038 |
|
224 |
180 |
$2K |
| 87070 |
|
219 |
206 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
151 |
73 |
$2K |
| 36012 |
|
15 |
15 |
$2K |
| 94729 |
|
95 |
72 |
$2K |
| 86021 |
|
346 |
128 |
$2K |
| 86336 |
|
120 |
104 |
$2K |
| 82962 |
|
602 |
487 |
$2K |
| 85660 |
|
388 |
297 |
$2K |
| 85018 |
|
1,479 |
1,033 |
$1K |
| 86480 |
|
28 |
25 |
$1K |
| 85014 |
|
1,486 |
1,038 |
$1K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,142 |
939 |
$1K |
| 83550 |
|
205 |
175 |
$1K |
| 76801 |
|
13 |
12 |
$1K |
| 82945 |
|
234 |
100 |
$1K |
| 87186 |
|
191 |
163 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,620 |
3,590 |
$1K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
81 |
78 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
69 |
62 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,131 |
2,434 |
$1K |
| 85027 |
|
195 |
171 |
$1K |
| 94761 |
|
311 |
166 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,840 |
2,221 |
$1K |
| 72040 |
|
30 |
27 |
$1K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
146 |
111 |
$1K |
| 83540 |
|
199 |
176 |
$963.68 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,559 |
2,219 |
$894.77 |
| 94010 |
|
30 |
26 |
$818.37 |
| 73630 |
|
30 |
12 |
$813.78 |
| 86431 |
|
198 |
153 |
$728.91 |
| 74018 |
|
27 |
24 |
$722.15 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
400 |
326 |
$706.36 |
| 82951 |
|
94 |
87 |
$695.61 |
| 83655 |
|
56 |
53 |
$691.98 |
| J2060 |
Injection, lorazepam, 2 mg |
516 |
417 |
$644.34 |
| 83605 |
|
110 |
79 |
$613.21 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
524 |
357 |
$601.55 |
| 86334 |
|
34 |
28 |
$590.48 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
75 |
69 |
$588.87 |
| 84166 |
|
34 |
28 |
$526.97 |
| J1644 |
Injection, heparin sodium, per 1000 units |
448 |
366 |
$469.47 |
| 83615 |
|
84 |
68 |
$428.84 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
310 |
259 |
$410.17 |
| 73030 |
|
21 |
12 |
$344.63 |
| 72084 |
|
13 |
13 |
$342.48 |
| 84144 |
|
16 |
15 |
$333.76 |
| 80069 |
|
45 |
39 |
$303.80 |
| 86147 |
|
24 |
12 |
$297.15 |
| 80051 |
|
84 |
61 |
$285.09 |
| 82803 |
|
73 |
67 |
$279.49 |
| 86308 |
|
55 |
49 |
$264.50 |
| 84403 |
|
15 |
12 |
$258.10 |
| 85045 |
|
66 |
64 |
$255.36 |
| J2704 |
Injection, propofol, 10 mg |
3,968 |
3,109 |
$253.93 |
| 86141 |
|
32 |
27 |
$233.10 |
| J3490 |
Unclassified drugs |
204 |
69 |
$232.67 |
| 84140 |
|
12 |
12 |
$227.37 |
| 82627 |
|
15 |
12 |
$222.30 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
14 |
13 |
$198.96 |
| J7510 |
Prednisolone oral, per 5 mg |
73 |
66 |
$195.11 |
| 82952 |
|
60 |
60 |
$188.16 |
| 83001 |
|
15 |
12 |
$185.80 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
184 |
149 |
$181.86 |
| 86255 |
|
32 |
26 |
$180.75 |
| 83002 |
|
15 |
12 |
$166.68 |
| 96523 |
|
165 |
115 |
$162.38 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
16 |
13 |
$129.20 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
111 |
94 |
$120.45 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
69 |
40 |
$119.71 |
| 84703 |
|
20 |
16 |
$108.68 |
| 86704 |
|
15 |
12 |
$108.45 |
| 86705 |
|
15 |
12 |
$105.93 |
| 83525 |
|
18 |
14 |
$102.87 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
447 |
338 |
$91.41 |
| 87077 |
|
17 |
14 |
$89.70 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
172 |
133 |
$87.77 |
| 85613 |
|
13 |
12 |
$76.64 |
| C9113 |
Injection, pantoprazole sodium, per vial |
44 |
26 |
$68.54 |
| 84270 |
|
15 |
12 |
$62.40 |
| 85041 |
|
563 |
294 |
$56.21 |
| 87205 |
|
17 |
14 |
$34.16 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
42 |
29 |
$28.65 |
| 84155 |
|
73 |
28 |
$22.42 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
25 |
13 |
$15.01 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
45 |
40 |
$6.70 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
37 |
14 |
$0.80 |
| 90791 |
Psychiatric diagnostic evaluation |
294 |
248 |
$0.00 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
8,584 |
658 |
$0.00 |
| G0177 |
Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) |
4,180 |
735 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
109 |
67 |
$0.00 |
| 90832 |
Psychotherapy, 30 minutes with patient |
796 |
559 |
$0.00 |
| 36005 |
|
34 |
27 |
$0.00 |
| 02414 |
|
27 |
27 |
$0.00 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
108 |
67 |
$0.00 |
| C1780 |
Lens, intraocular (new technology) |
109 |
66 |
$0.00 |
| G0410 |
Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes |
16,049 |
1,081 |
$0.00 |
| 00000 |
|
1,890 |
1,413 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
18 |
13 |
$0.00 |
| 80329 |
|
471 |
187 |
$0.00 |
| L8699 |
Prosthetic implant, not otherwise specified |
14 |
13 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
17 |
12 |
$0.00 |